Lisata Therapeutics, Inc. LSTA 深 滬
已收盤 02-06 16:00:00 美东时间
4.54
-0.060
-1.30%
華盛通- 最 高4.655
- 今 開4.62
- 成交量 12.78万股
- 最 低 4.54
- 昨 收 4.60
- 總市值 4004.61万
- 52周最高 4.8918
- 市盈率 靜 --
- 換手率 1.45%
- 52周最低 1.81
- 委 比 80.00%
- 總股本 882.07万
- 歷史最高 1483.50
- 量 比 1.04
- 振 幅 2.50%
- 歷史最低 1.81
- 每 手 1
- 風險率 0.51%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Lisata Therapeutics ends Qilu certepetide collaboration deal
Lisata Therapeutics ( ($LSTA) ) just unveiled an announcement. On January 23, 2...
01-27 21:48
BUZZ-U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
BUZZ-U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks staged a modest recovery on Wednesday after the sharpest equities se
01-22 02:53
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers PAVmed (NASDAQ:PAVM) stock increased by 250.7% to $21.71 during Wednes...
01-22 01:05
Brookline Capital Downgrades Lisata Therapeutics to Hold
Brookline Capital analyst Kemp Dolliver downgrades Lisata Therapeutics (NASDAQ:LSTA) from Buy to Hold.
01-22 00:04
BUZZ-U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
BUZZ-U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks staged a modest recovery on Wednesday after the sharpest e
01-21 23:49
Why Is Lisata Therapeutics Stock Gaining Today?
Lisata Therapeutics shares surged premarket after Kuva Labs agreed to acquire the company for $4 per share in cash plus two milestone-based CVRs.
01-21 23:31
Lisata Therapeutics To Be Acquired By Kuva Labs In $4.00/Share Tender Offer
Stockholders to also receive two contingent value rights valued at $1 per share, each entitled to be received upon the achievement of certain milestonesOffer represents an approximate 85% premium over the most recent
01-21 20:03
Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
Lisata Therapeutics has entered into a binding term sheet to be acquired by Kuva Labs for $4.00 per share in cash, representing an 85% premium over its recent stock price. Shareholders will also receive two contingent value rights (CVRs) worth $1.00 each, contingent on certain milestones. The transaction, approved by both companies' boards, values Lisata's clinical pipeline and lead product certepetide, a novel anti-cancer therapy. Kuva plans to ...
01-21 12:00
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers MoonLake (NASDAQ:MLTX) stock rose 8.2% to $20.0 during Friday's after-...
01-10 05:05
电话会总结 ｜ Lisata(LSTA)2025财年Q3业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Lisata Therapeutics 2025年第三季度业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **运营费用表现：** - 2025年第三季度运营费用为440万美元，较2024年同期的530万美元下降90万美元 - 研发费用为200万美元，较2024年同期的250万美元减少60万美元 - 一般管理费用为250万美元，较2024年同期的280万美元减少30万美元 - 净亏损为420万美元，较2024年同期的490万美元有所改善 **现金状况：** - 截至2025年第三季度末，现金及现金等价物为1900万美元 - 公司预计现有
2025-11-10 12:01
